Cabaletta Bio (CABA) Cash from Operations (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.42% |
| Sep 30, 2025 | -13.42% |
| Jun 30, 2025 | 1.22% |
| Mar 31, 2025 | -33.22% |
| Dec 31, 2024 | -13.77% |
| Sep 30, 2024 | 2.24% |
| Jun 30, 2024 | 13.34% |
| Mar 31, 2024 | -45.84% |
| Dec 31, 2023 | -30.50% |
| Sep 30, 2023 | -6.01% |
| Jun 30, 2023 | 5.70% |
| Mar 31, 2023 | -3.93% |
| Dec 31, 2022 | -22.36% |
| Sep 30, 2022 | 13.99% |
| Jun 30, 2022 | 10.02% |
| Mar 31, 2022 | -21.82% |
| Dec 31, 2021 | -26.02% |
| Sep 30, 2021 | -26.81% |
| Jun 30, 2021 | 24.11% |
| Mar 31, 2021 | 5.48% |
| Dec 31, 2020 | -82.58% |
| Sep 30, 2020 | 34.26% |
| Jun 30, 2020 | -54.98% |
| Mar 31, 2020 | 37.45% |
| Dec 31, 2019 | -279.72% |
| Sep 30, 2019 | 45.67% |
| Jun 30, 2019 | -68.70% |
| Mar 31, 2019 | -18.71% |